Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

DEUS

Xtrackers Russell US Multifactor ETF (DEUS)

Rating:71Outperform
Price Target:$72.00â–²(8.00% Upside)

DEUS, the Xtrackers Russell US Multifactor ETF, earns a solid overall rating thanks to several high-quality holdings with strong financial performance and growth prospects, such as Regeneron, United Therapeutics, and Travelers, which bring robust revenue, profitability, and supportive valuations to the portfolio. Some holdings like McKesson and ADM introduce risks through high leverage, weaker margins, and bearish technical signals, and the fund’s concentration in U.S. companies means its results are closely tied to the health of the U.S. economy and market conditions.

Positive Factors
Strong Recent PerformanceThe ETF has shown strong gains so far this year, which suggests its multifactor strategy has been working well in the current market.
Solid Top HoldingsMany of the largest positions, including companies in financials, health care, and technology, have delivered strong year-to-date performance that supports the fund’s returns.
Broad Sector DiversificationThe fund spreads its investments across many sectors such as industrials, health care, financials, technology, and consumer stocks, helping reduce the impact if any one industry struggles.
Negative Factors
Heavy U.S. FocusWith almost all assets in U.S. companies and very little in Canada, the ETF offers limited geographic diversification and is highly tied to the U.S. economy.
Modest Fund SizeThe ETF has a relatively moderate level of assets under management, which can sometimes mean less trading volume and wider bid-ask spreads for investors.
Short-Term Performance BumpThe one-month performance has been strong compared with the more muted three-month results, which may indicate that some of the recent gains are more short-term in nature.

DEUS vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%25%SPY+8.76%DEUS+17.44%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
301.56M
Region
North America
Expense Ratio
0.17%
Beta
0.62
Issuer
Xtrackers
Inception Date
Nov 24, 2015
Dividend Yield
1.39%
Asset Class
Equity
Index Tracked
Russell 1000 Comprehensive Factor Index

DEUS Summary

DEUS is the Xtrackers Russell US Multifactor ETF, which follows the Russell 1000 Comprehensive Factor Index. It invests in many large U.S. companies and tilts toward stocks that look attractive on measures like value, quality, and price trends. The fund holds well-known names such as Allstate and Archer Daniels Midland, and spreads money across sectors like financials, health care, and technology. Someone might invest in DEUS to get broad, diversified exposure to big U.S. companies with a rules-based approach to picking stocks. A key risk is that its value can go up or down with the overall stock market.

How much will it cost me?

This ETF has an expense ratio of 0.17%, which means you’ll pay about $1.70 per year for every $1,000 invested. That’s slightly higher than the cheapest plain index ETFs because it uses an actively designed multifactor strategy, but it’s still relatively low-cost overall.

What would affect this ETF?

Future performance of DEUS will be influenced by the health of the overall U.S. economy, since it focuses on large American companies across many sectors like industrials, health care, and financials, and by how well its top holdings such as Allstate, McKesson, and Archer Daniels Midland manage profits and business risks. Rising interest rates, tighter financial regulations, or weakness in economically sensitive areas like consumer and industrial stocks could hurt returns, while stable or improving economic growth, supportive central bank policy, and strong earnings from its diversified mix of sectors and factor-focused strategy could be positive drivers.

DEUS Top 10 Holdings

DEUS is quietly powered by a mix of U.S. insurers, health-care names, and industrials rather than the usual Big Tech suspects. Regeneron, McKesson, and United Therapeutics have been rising steadily, giving the fund a healthy dose of momentum from the biotech and pharma corner. On the financial side, Travelers, Cincinnati Financial, and Allstate are pulling their weight, though Allstate’s recent choppiness has taken a bit of shine off. ADM and Simon Property are more mixed, occasionally acting as speed bumps, but overall the fund leans on diversified, U.S.-centric stalwarts rather than high-flying growth stories.

DEUS top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
ALLALLAllstate0.98%$2.95M$63.05B28.69%74Outperform
MCKMCKMcKesson0.91%$2.74M$122.48B23.55%62Neutral
REGNREGNRegeneron0.78%$2.34M$93.54B39.80%78Outperform
ADMADMArcher Daniels Midland0.76%$2.27M$33.30B23.36%64Neutral
SPGSPGSimon Property0.60%$1.78M$73.91B26.38%70Outperform
TRVTRVTravelers Companies0.56%$1.68M$80.99B43.05%78Outperform
CBOECBOECboe Global Markets0.55%$1.66M$36.86B39.83%75Outperform
CINFCINFCincinnati Financial0.55%$1.64M$28.47B14.93%76Outperform
TROWTROWT Rowe Price0.54%$1.62M$23.13B6.13%75Outperform
ACGLACGLArch Capital Group0.53%$1.59M$34.92B22.24%79Outperform

DEUS Technical Analysis

Technical Analysis SentimentNeutral
Last Price66.67

Price Trends

50DMA65.76Positive
100DMA66.03Positive
200DMA63.90Positive

Market Momentum

MACD0.56Negative
RSI51.31Neutral
STOCH44.34Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DEUS, the sentiment is Neutral. The current price of 66.67 is above the 20-day moving average (MA) of 66.65, above the 50-day MA of 65.76, and above the 200-day MA of 63.90, indicating a bullish trend. The MACD of 0.56 indicates Negative momentum. The RSI at 51.31 is Neutral, neither overbought nor oversold. The STOCH value of 44.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DEUS.

DEUS Peer Comparison

Comparison Results

DEUS against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
DEUSDEUS$66.67$72.00(8.00% Upside)$301.56M0.17%71Outperform
DSPYDSPY$64.19$77.80(21.20% Upside)$984.35M0.18%72Outperform
CVLCCVLC$91.13$114.13(25.23% Upside)$962.87M0.15%71Outperform
INFOINFO$26.85$33.59(25.12% Upside)$913.48M0.35%74Outperform
AFLGAFLG$42.87$52.27(21.92% Upside)$907.38M0.55%74Outperform
ROCYROCY$53.02$65.68(23.87% Upside)$876.48M0.35%73Outperform

Performance Comparison

0%10%DEUSDSPYCVLCINFOAFLGROCYDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DEUS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DEUSXtrackers Russell US Multifactor ETF66.679.2116.03%
DSPYTema S&P 500 Historical Weight ETF Strategy64.196.4711.21%
CVLCCalvert US Large-Cap Core Responsible Index ETF91.137.368.78%
INFOHarbor PanAgora Dynamic Large Cap Core ETF26.852.339.51%
AFLGFirst Trust Active Factor Large Cap ETF42.873.889.94%
ROCYJPMorgan Equity Premium Yield ETF53.025.2410.98%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.